Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Reynolds

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
Current Oncology Reports|December 21, 2000
Differentiating agents in pediatric malignancies: retinoids in neuroblastomaC P Reynolds
Progress in Clinical and Biological Research|January 1, 1985
Modulation of cell surface antigens accompanies morphological differentiation of human neuroblastoma cell linesC P Reynolds, J Maples
Journal of Pediatric Hematology/Oncology|April 18, 2001
Detection of minimal residual disease in bone marrow during or after therapy as a prognostic marker for high-risk neuroblastomaC P Reynolds, R C Seeger
Hematology/Oncology Clinics of North America|January 5, 2002
Retinoid therapy of childhood cancerC P Reynolds, R S Lemons
Pediatric Clinics of North America|April 1, 1991
Treatment of high-risk solid tumors of childhood with intensive therapy and autologous bone marrow transplantationR C Seeger, C P Reynolds
Bone Marrow Transplantation|August 22, 2002
Synergistic cytotoxicity of buthionine sulfoximine (BSO) and intensive melphalan (L-PAM) for neuroblastoma cell lines established at relapse after myeloablative therapyC P Anderson, C P Reynolds
Cancer Chemotherapy and Pharmacology|January 1, 1989
Determination of subcutaneous tumor size in athymic (nude) miceM M Tomayko, C P Reynolds
Journal of Biochemical and Biophysical Methods|June 1, 1987
Automation of protein assays with a microcomputer interfaced to a spectrophotometerS M Ross, C P Reynolds
Diagnostic and Clinical Immunology|January 1, 1987
Monoclonal antibody recognizing a human neuroblastoma-associated antigenR G Smith, C P Reynolds
British Journal of Cancer|October 12, 2000
Is there a role for retinoids to treat minimal residual disease in neuroblastoma?K K Matthay, C P Reynolds
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
Current Oncology Reports|December 21, 2000
Differentiating agents in pediatric malignancies: retinoids in neuroblastomaC P Reynolds
Progress in Clinical and Biological Research|January 1, 1985
Modulation of cell surface antigens accompanies morphological differentiation of human neuroblastoma cell linesC P Reynolds, J Maples
Journal of Pediatric Hematology/Oncology|April 18, 2001
Detection of minimal residual disease in bone marrow during or after therapy as a prognostic marker for high-risk neuroblastomaC P Reynolds, R C Seeger
Hematology/Oncology Clinics of North America|January 5, 2002
Retinoid therapy of childhood cancerC P Reynolds, R S Lemons
Pediatric Clinics of North America|April 1, 1991
Treatment of high-risk solid tumors of childhood with intensive therapy and autologous bone marrow transplantationR C Seeger, C P Reynolds
Bone Marrow Transplantation|August 22, 2002
Synergistic cytotoxicity of buthionine sulfoximine (BSO) and intensive melphalan (L-PAM) for neuroblastoma cell lines established at relapse after myeloablative therapyC P Anderson, C P Reynolds
Cancer Chemotherapy and Pharmacology|January 1, 1989
Determination of subcutaneous tumor size in athymic (nude) miceM M Tomayko, C P Reynolds
Journal of Biochemical and Biophysical Methods|June 1, 1987
Automation of protein assays with a microcomputer interfaced to a spectrophotometerS M Ross, C P Reynolds
Diagnostic and Clinical Immunology|January 1, 1987
Monoclonal antibody recognizing a human neuroblastoma-associated antigenR G Smith, C P Reynolds
British Journal of Cancer|October 12, 2000
Is there a role for retinoids to treat minimal residual disease in neuroblastoma?K K Matthay, C P Reynolds
Pageof 12